Scalable Synthesis and New Bond Disconnections
可扩展的合成和新的键断裂
基本信息
- 批准号:9677411
- 负责人:
- 金额:$ 9.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAlkaloidsAlkenesArchitectureBiochemical PathwayBiologicalBiomedical ResearchBreathingCarbonChemicalsChemistryCollaborationsComplexDevelopmentDimerizationDrug IndustryElectrochemistryEnvironmentFDA approvedFamilyFluorineFolk MedicineGoalsHuman bodyHydrogen BondingIndustrializationKnowledgeLaboratoriesLiteratureMethodologyMethodsModernizationNatural ProductsNatureOrganic ChemistryPharmaceutical ChemistryPharmaceutical PreparationsPharmacologic SubstanceProceduresPropertyReagentResearchScientistSourceTerpenesTranscendcostfield studyinterestnoveloxidationprogramsscaffoldsuccess
项目摘要
BARAN, PHIL S.
PROJECT SUMMARY/ABSTRACT
Natural products have long held societal value as folk medicines, and even in this modern era, many
FDA-approved drugs are still being derived from terpenes and alkaloids found in nature. Biomedical
research has also benefited from natural products, as previously unknown mechanisms of action have been
discovered while studying the unique biochemical pathways that these compounds undergo in the human
body. Furthermore, endeavors in the total synthesis of these architecturally diverse compounds have
continuously provided chemists with challenges, which in turn have led to the establishement of research
programs in both academic and industrial environments. Ever since its inception, our laboratory has been
pursuing, and has succeeded in, the total synthesis of iconic natural products in both the terpene and
alkaloid families. These syntheses have identified gaps in the chemical literature, which we have
subsequently addressed. The products of this research program—new synthetic strategies, unprecedented
transformations and novel reagents—have in turn enabled the synthesis of even more natural products and
pharmaceutically relevant motifs, thus completing a catalytic cycle of discovery. We seek to replicate this
success with the current proposal: the described projects will target complex natural products to identify
shortcomings in chemical methodology, while simultaneously devising methods of widespread interest,
followed by the assessment of their practicality in the synthesis of complex molecules.
This proposal is organized into three parts with the overarching goal of generating chemical
knowledge that transcends the original objective of natural product synthesis. The first section delineates
plans for late-stage oxidation to efficiently synthesize complex terpene and alkaloid natural products. The
second portion of the proposal argues that electrochemistry can be a practical, inexpensive, non-toxic, and
scalable solution to a variety of chemistry problems, wherein dimerization of N–H bonds for natural product
synthesis, heteroarene fluorination for pharmaceutical development, and allylic oxidation for the
functionalization of terpene-type frameworks are presented. Lastly, the third section illustrates the versatile
reactivity of olefin-derived, carbon-centered radicals to forge C–C and C–N bonds that are otherwise
impractical or impossible to create. The resulting procedures will be utilized in the construction of complex
and sterically encumbered pharmaceutical motifs, which will serve to expand chemical space and
accelerate discovery in medicinal chemistry. Notably, we have already established numerous collaborations
to study the biological properties of the products that will be synthesized, to validate and field-test new
methods, and to commercialize reagents for widespread adoption in both academic and industrial settings.
菲尔·巴兰
项目总结/摘要
天然产品作为民间药物长期以来一直具有社会价值,即使在这个现代时代,
FDA批准的药物仍然来自自然界中发现的萜烯和生物碱。生物医学
研究也受益于天然产品,因为以前未知的作用机制已经被发现。
在研究这些化合物在人体内的独特生化途径时发现的
身体此外,在这些结构上不同的化合物的全合成方面的努力已经取得了进展。
不断为化学家提供挑战,这反过来又导致了研究的建立
在学术和工业环境中的计划。自成立以来,我们的实验室一直
追求,并已成功地,在萜烯和
生物碱家族这些合成已经确定了化学文献中的空白,
随后处理。这项研究计划的产物-新的合成策略,前所未有的
转化和新试剂-反过来又使得能够合成更多的天然产物,
药物相关的基序,从而完成发现的催化循环。我们试图复制这种
目前提案的成功:所述项目将针对复杂的天然产品,
化学方法的缺点,同时设计出广泛关注的方法,
然后评估它们在合成复杂分子中的实用性。
该提案分为三个部分,其总体目标是产生化学品,
超越天然产物合成的原始目标的知识。第一部分描述了
后期氧化高效合成复杂萜类和生物碱类天然产物的方案。的
该提案的第二部分认为,电化学可以是一种实用、廉价、无毒,
一个可扩展的解决方案,以各种化学问题,其中N-H键的二聚天然产物
合成,用于药物开发的杂芳烃取代,以及用于
功能化的term类型的框架。最后,第三部分说明了通用的
烯烃衍生的碳中心自由基形成C-C和C-N键的反应性
不切实际的或不可能创造的。由此产生的程序将用于建设复杂的
和空间阻碍的药物基序,这将有助于扩大化学空间,
加速药物化学的发现值得注意的是,我们已经建立了许多合作关系,
研究将要合成的产品的生物特性,验证和实地测试新的
方法,并将试剂商业化以在学术和工业环境中广泛采用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHIL S BARAN其他文献
PHIL S BARAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHIL S BARAN', 18)}}的其他基金
Transcriptional silencing of latent HIV infection - a novel small molecule class
潜伏 HIV 感染的转录沉默——一类新型小分子
- 批准号:
8731293 - 财政年份:2014
- 资助金额:
$ 9.62万 - 项目类别:
Preparative Radical Chemistry for Biomedical Research
生物医学研究的制备自由基化学
- 批准号:
8996063 - 财政年份:2013
- 资助金额:
$ 9.62万 - 项目类别:
Preparative Radical Chemistry for Biomedical Research
生物医学研究的制备自由基化学
- 批准号:
8795737 - 财政年份:2013
- 资助金额:
$ 9.62万 - 项目类别:
Preparative Radical Chemistry for Biomedical Research
生物医学研究的制备自由基化学
- 批准号:
8485337 - 财政年份:2013
- 资助金额:
$ 9.62万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 9.62万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 9.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 9.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 9.62万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 9.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 9.62万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 9.62万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 9.62万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 9.62万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 9.62万 - 项目类别:
Standard Grant